Member Info for Tenzan

It's clear from the RNS wording, and really bad reporting from the BBC and The Guardian

'Pursuant to Rule 2.4(c)(iii) of the Code, if Castlelake were to make an offer for the Company, under Rule 6 of the Code Castlelake would be required to make an offer at no less than 403.23 pence per share.

20% to 30% premium = c.£5; still opportunistic IMO

If Bharti increased his stake to 29.9 %, for example, it creates a 'blocking stake' without the need for a full takeover. It may be a protective manuvere on his part. Given he's had a positive influence IMO, this would hopefully continue to be in BTs interests

'A blocking stake (often called a blocking minority) is a specific percentage of voting shares in a company that allows a shareholder or group of shareholders to veto major corporate decisions, such as mergers, acquisitions, or charter amendments.

Depending on local corporate governance laws and a company's articles of association...'

Great advert from BT "Behind Brilliant Things". Thought it summed up the importance of the company and what it offers, which is more than any altnet, or in fact, more major suppliers - the BAE contract, for example. Clever

Both Bank of America and JP Morgan also raising potential dividends for 2028 onwards, c.11p and double, (16p) in JP Morgan's analysis. That's good for pension funds. It's certainly all adding momentum :)

BT just needs to get it's own pension commitments down and we're really rolling

A cautious response...

Mark Shurmer, MD for Regulation at Openreach, told ISPreview:

“No one is going further or faster than us to build the UK’s best network(s). Our investments help customers – and the country – do brilliant things, but they only happen when the environment is stable and supportive. That’s why Ofcom’s review is critical to the future of digital connectivity across the UK.

But this is a complex document that we need to review in full. We’ll continue to work with Ofcom to make sure the regulation set today will allow fair competition within that market to get the best results for consumers.

This market is evolving rapidly and, with competition more intense than ever, it’s really important that regulation keeps pace with that change.”

I check in now and again to see people's opinions & thoughts on the company/share price. Seriously, what an absolute joke the current poster's comments are. I hear better from 5yr olds. Grow up, and contribute something useful

When you say 'Kaiser Pickelhaube correction' does it look something like this:

https://www.kaisersbunker.com/goodbye/g15.htm

That's how I feel when I think about the share price...

*cigarette packet*

just did a *** packet calculation of carlos slim's current profit on his bt shareholding. at a very possible 40% increase, that would mean c. £156,000,000 profit, not including dividends. i wonder what that feels like :)

And you can trade in both. The limit for cash ISAs may change. Key thing £20,000 limit (i.e. paid into total number of ISAs per year).

This is from the HL website:

Can I pay into more than one Stocks and Shares ISA?

Yes, you can into more than one Stocks and Shares ISA in the same tax year.

You can also spread your £20,000 ISA limit across any combination of Stocks and Shares, Innovative Finance or Cash ISAs. However, you can only pay into one Lifetime ISA each tax year (up to £4,000 per year) if eligible.

For example, if you wanted to divide your ISA allowance between cash and investments, you could put £15,000 in a Stocks and Shares ISA and the remaining £5,000 in a Cash ISA.

On top of the £20,000 ISA allowance, it’s also possible to pay up to £9,000 into a Junior ISA for a child.

The transcripts of the class action can be found here:

https://www.catribunal.org.uk/cases/13817721-justin-le-patourel

Just a question to those more knowledgeable: There have been 22,083 shares sold and 89,902 bought (a sea of blue for the last hour!), and yet the share price is down. How does that work? Most are AT trades - does this have something to do with it? Cheers, Tenzan

Out of interest, just looked at the pipeline, which includes Prevascar and the website indicates that: 'Although Prevascar is targeted at the same potential market as Juvista, i.e. prophylactic improvement of scar appearance in the skin, its mechanism of action is different to, and distinct from, that of Juvista.' So, perhaps some hope...

The issue is whether these drugs are based on a similar technology. Can Juvista be developed further? This is the second failure, after a dosage issue first time around, so some serious questions have to be asked.